The proteolysis of VWF by ADAMTS13 is an essential step in the regulation of its hemostatic and thrombogenic potential. The cleavage occurs at strand ␤4 in the structural core of the A2 domain of VWF, so unfolding of the A2 domain is a prerequisite for cleavage. In the present study, we present the crystal structure of an engineered A2 domain that exhibits a significant difference in the ␣3-␤4 loop compared with the previously reported structure of wild-type A2. Intriguingly, a metal ion was detected at a site formed mainly by the C-terminal region of the ␣3-␤4 loop that was later identified as Ca 2؉ after various biophysical and biochemical studies. Force-probe molecular dynamic simulations of a modeled structure of the wild-type A2 featuring the discovered Ca 2؉ -binding site revealed that an increase in force was needed to unfold strand ␤4 when 
Introduction
VWF plays an important role in primary hemostasis by mediating platelet adhesion. VWF is stored in endothelial Weibel-Palade bodies and platelet ␣-granules as glycosylated multimers consisting of the largest multimeric species, ultra-large VWF. [1] [2] [3] [4] Upon stimulation, the VWF multimers are released into the circulating blood or subendothelial matrix. Within 2 hours after release into the vessel, the secreted ultra-large VWF multimers are converted by ADAMTS13 proteolysis into smaller multimers ranging from 500-20 000 kDa. [5] [6] [7] [8] The cleavage site for ADAMTS13 resides at the Tyr1605-Met1606 bond in the A2 domain, 1,9 a cryptic site buried in the central ␤-strand in the intact, folded A2 domain that is inaccessible to ADAMTS13. 10 More than a decade ago, it was observed that shear stress promotes the process of VWF proteolysis. 11 Since that time, a large body of evidence has supported the notions that the conformation of VWF fibers is altered by shear stress 12 and that unfolding of VWF by shear stress leads to enhanced susceptibility of the VWF to ADAMTS13 proteolysis. [13] [14] [15] Because the hemostatic potential of VWF greatly increases with its length, cleavage by ADAMTS13 provides an important regulatory mechanism for primary hemostasis. The cleavage process is precisely regulated in vivo, and dysfunction of this regulation can lead to severe consequences. For example, mutations in VWF that cause increased susceptibility of VWF to ADAMTS13 lead to a shift of the multimer distribution to smaller forms with less hemostatic potential, resulting in continuous bleeding diseases known as VWD. 16, 17 Most mutations in the A2 domain that are associated with VWD type 2A, the common qualitative defect of VWD, result in enhanced proteolytic susceptibility. 18 Recently, it was clearly shown that unfolding of A2 is required for its cleavage by ADAMTS13, and an intermediate state exists with unfolding of the C-terminal region up to and including the ␤4 strand where the cleavage site is located. 19 Further information about the stepwise unfolding of A2 under tensile stress and the consequent exposure of the ADAMTS13 cleavage site were revealed by simulations of force-probe molecular dynamics (MD). 20 To further understand the molecular mechanism underlying the shear force-induced cleavage of the VWF A2 domain by ADAMTS13, we carried out structural and functional studies of the A2 domain. We constructed an engineered A2 domain (N1493C/C1670S, ssA2) by introducing an A1/A3-like disulfide bond 20 that allowed us to perform further structural studies. While we solved the crystal structure of the engineered A2 domain, Zhang et al reported the crystal structure of a wild-type A2 (wtA2) domain, which provided structural insights into the mechanism of its shear force sensor function. 21 Compared with the wtA2 domain, our ssA2 structure reveals a novel Ca 2ϩ -binding site on the ␣3-␤4 loop that is absent in the wtA2 structure. To investigate the potential functional role of Ca 2ϩ binding in the shear forcedependent cleavage of the VWF A2 domain by ADAMTS13, we performed MD simulations, mutagenesis studies, and in vitro biochemical assays. Our results show that the binding of Ca 2ϩ stabilizes the A2 domain and impedes its unfolding, thus decreasing the susceptibility of the A2 domain to ADAMTS13 proteolysis. Our structural and biochemical data provide new insights into the regulation of VWF cleavage by ADAMTS13 in hemostasis and thrombosis.
Methods

Cloning, expression, and purification of VWF A2 domain
The gene fragment of the VWF A2 domain (residues Leu1487-Gly1674) was amplified from the cDNA of HEK293T cells and inserted into pET22b (Novagen). An engineered A2 domain (ssA2) that contains the N1493C and C1670S mutations was generated to introduce a disulfide bond that links the N-and C-termini of the A2 domain in a manner analogous to that in the VWF A1 and A3 domains. 20 The ssA2 protein and its mutants were expressed in E coli BL21 (DE3) CodonPlus cells. The proteins were purified with nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography followed by gel filtration. The target proteins were concentrated to 15 mg/mL in buffer A (20mM Tris-HCl, pH 8.0, 300mM NaCl, 10% glycerol, and 0.1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate) for crystallization. For inductively coupled plasma atomic emission spectroscopy analysis, the purified ssA2 protein was further dialyzed against buffer B (3mM Tris-HCl, pH 8.0).
For cleavage assays, the wild-type and mutant wtA2 proteins were expressed in HEK293S GNT1 Ϫ cells, as described previously. 21 The target proteins were purified by Ni-NTA affinity chromatography. VWF73 (residues Asp1596-Arg1668) was shown to be the minimal substrate for ADAMTS13. 22 The VWF73 gene fragment with a C-terminal hexahistidine tag was inserted into pGEX4T1. The wild-type and mutant glutathione S-transferase (GST)-VWF73 proteins were expressed in E coli BL21 (DE3) CodonPlus cells and purified by Ni-NTA followed by GST affinity chromatography. The purified wtA2 and VWF73 proteins were dialyzed against buffer C (50mM HEPES, pH 7.4, and 150mM NaCl) for cleavage assays.
Crystallization, diffraction data collection, and structure determination and refinement
Crystallization experiments were carried out at 4°C using the hanging drop vapor diffusion method. The crystals of ssA2 and its mutants were grown in drops containing equal volumes of the protein solution and the crystallization solution (0.1M sodium citrate, pH 5.2, and 1.6M [NH 4 ] 2 SO 4 ). The crystals were cryoprotected with the reservoir solution supplemented with 25% glycerol and then flash-frozen in liquid nitrogen. X-ray diffraction data were collected at Ϫ173°C at beam-line 17U of the Shanghai Synchrotron Radiation Facility (Shanghai, China) at a wavelength of 1.0000 Å using a MAR225 detector, and were processed using the HKL2000 (Version 0.98. 698x, HKL Research Inc) software suite. 23 Diffraction data statistics are summarized in Table 1 .
The ssA2 structure was determined using the molecular replacement method with PHASER (Version 2.1.4; Phaser Scientific Software LLC) 24 25 as a search model. The initial structure refinement was carried out with CNS (Version 1.2) 26 and the manual model building was performed with COOT (Version 8.4.1). 27 In the initial difference Fourier maps, it was evident that a disulfide Generously allowed regions, % 0.6 0.6 0.6 0.6 RMSD indicates root mean square deviation; and ASU, asymmetric unit. *Numbers in parentheses refer to the highest-resolution shell.
bond formed between Cys1493 and Cys1669, and strong electron density corresponding to a metal ion was detected near the ␣3-␤4 loop (the nomenclature of the secondary structures of ssA2 adopts that of wtA2 by Zhang et al 21 ) , which was further identified as a Ca 2ϩ ion (see "Results").
The final structure refinement was performed with REFMAC5. 28 The structures of the ssA2 mutants were determined using the ssA2 structure as the starting model. The statistics of the structure refinement and the final structure models are listed in Table 1 .
Force-probe MD simulations
Molecular modeling and in silico mutagenesis were performed with MOE (2009.10, Chemical Computing Group CCG). A wtA2 model (residues 1495-1671) was constructed based on the ssA2 structure by mutations of Cys1493 back to Asn and Ser1670 back to Cys and subsequent generation of a vicinal disulfide bridge between Cys1669 and Cys1670. The assigned Ca 2ϩ ion was kept or replaced with a water molecule. All MD simulations and analyses were carried out with the Gromacs suite (version 3.3.3) 29 and the OPLS all-atom force field. 30 For the equilibrium MD simulations, the protein was solvated in dodecahedral boxes with at least 5500 TIP4p water molecules 31 under periodic boundary conditions. The typical protonation states at pH 7 were chosen for ionizable groups of the protein and the necessary amount of counter-ions (Cl Ϫ and Na ϩ ) were added to ensure a neutral system of physiologic ion strength. A temperature of 27°C and a pressure of 1 bar were assumed. The wtA2 models were simulated each for at least 20 nanoseconds and up to 40 nanoseconds.
For the force-probe MD simulations, the systems were solvated in 19-nm-long rectangular boxes each containing approximately 20 000 water molecules. Harmonic springs were attached to the terminal C ␣ atoms with spring constants of 500 kJ/(mol/nm 2 ) and then moved away from each other with a velocity of 1.25 nm/ns so that each of the simulations spanned approximately 26 nanoseconds. To keep the system size (ie, the simulation box size) reasonable, the force-probe MD simulations were split into 2 parts. In the beginning, the whole wtA2 domain (residues 1495-1671) was simulated until unfolding of the C-terminal secondary structure elements ␣6, ␤6, and ␣5 was completed. Subsequently, the unfolded region (residues 1634-1671) was removed and the force-probe MD simulations were continued with the truncated fragment.
A2 cleavage assays
The in vitro cleavage assays of the wtA2 and GST-VWF73 proteins included preincubation of the proteins with urea at different concentrations of Ca 2ϩ (step I), followed by administration of ADAMTS13 for the A2 cleavage (step II). In step I, 200 g/mL of A2 protein in the assay buffer (50mM HEPES, pH 7.5, 150mM NaCl, 50M ZnCl 2 , and 0.1% BSA) was incubated at 37°C for 2 hours with different concentrations of urea (1.92M, 2.56M, 3.20M, and 3.84M) and Ca 2ϩ (0mM, 2.5mM, and 5.0mM). For the VWF73 substrates, urea was not added. In step II, for each reaction, 5 L of the preincubated A2 protein in the assay buffer and 5 L of 20 g/mL ADAMTS13 (R&D Systems) in 50mM Tris-HCl (pH 8.5) were mixed and then incubated at 37°C for 1 hour with or without adjustment of the Ca 2ϩ concentration. In some assays, step I was omitted, and 5 L of the ssA2 protein in the assay buffer containing different concentrations of urea and Ca 2ϩ were incubated with 5 L of the diluted ADAMTS13 at 37°C for 3 hours. The cleaved C-terminal fragments of the A2 proteins and the intact A2 proteins were detected using Western blotting with the specific antibodies anti-A2C (R&D Systems) and anti-His (Tiangen Biotech), respectively. All experiments were performed at least 3 times.
Results
Crystal structure of VWF A2 domain
The wtA2 protein expressed with the E coli expression system was insoluble, and the refolded wtA2 did not show homogeneity and failed to produce any crystal. Thus, an engineered A2 domain (ssA2) was generated by introducing 2 mutations (N1493C and C1670S) to form a disulfide bond between the N-and C-termini analogous to that in the VWF A1 and A3 domains, 20 which allowed further structural studies.
The crystals of ssA2 belong to space group P6 5 (Table 1) , which is different from that of wtA2 (P2 1 ). 21 The asymmetrical unit contains one ssA2 molecule, corresponding to a Matthews coefficient of 2.3 Å 3 /Da and a solvent content of 46%. The ssA2 structure was determined at a 1.9 Å resolution, and was refined to an R factor of 20.1% and a free R factor of 23.1% (Table 1 ). The ssA2 structure assumes a typical Rossmann fold and is very similar to the wtA2 structure with a root mean square deviation of 1.0 Å for all C ␣ atoms ( Figure 1A-B) . As observed in the wtA2 structure (PDB code 3GXB), 21 Pro1645 takes a cis configuration.
A novel Ca 2؉ -binding site
The only major conformational difference between the ssA2 and wtA2 structures occurs in the region (residues 1591-1602) connecting ␣3 and ␤4. This region forms a short 3 10 helix in wtA2 but a loop in ssA2 ( Figure 1B ). The disulfide bond between Cys1493 and Cys1669 does not cause any notable conformational change in the nearby regions and therefore is unrelated to the observed conformational change of the ␣3-␤4 loop (supplemental Figure 1A , available on the Blood Web site; see the Supplemental Materials link at the top of the online article). Intriguingly, a metal ion is bound at this loop with evident electron density (supplemental Figure 1B) . It is coordinated in a octahedral geometry by 6 ligands: the main-chain carbonyls of Arg1597 (2.3 Å) and Ala1600 (2.3 Å), the side-chain carboxyl of Asp1498 (2.3 Å) and Asp1596 (2.4 Å), the side-chain carbonyl of Asn1602 (2.3 Å), and a water molecule (2.4 Å) ( Figure  1C ). The metal ion might be Ca 2ϩ because of the typical Ca 2ϩ -binding geometry. 32 At the equivalent site of wtA2, a molecule was also observed with 6 coordinating ligands ( Figure 1D ), which was assigned as a water molecule (see "Discussion").
To identify the type of the metal ion, we performed inductively coupled plasma atomic emission spectroscopy analyses of the protein solution and the buffer. The results showed a higher content of Ca 2ϩ ions (0.0042% vs 0.0011%) and Zn 2ϩ ions (0.0013% vs 0.0002%) in the protein solution than in the buffer alone ( Table 2 ), suggesting that the bound metal ion might have been Ca 2ϩ or Zn 2ϩ . For further verification, we collected anomalous dispersion data at the peak wavelengths of Zn 2ϩ (1.28 Å) and Ni 2ϩ (1.49 Å) and the most commonly used wavelength for Ca 2ϩ (1.77 Å), respectively. Evident anomalous signal was only detected at the metal-binding site at the wavelength of 1.77 Å (supplemental Figure 2A) , indicating that the bound metal ion was Ca 2ϩ rather than Zn 2ϩ or Ni 2ϩ . Because no Ca 2ϩ and Zn 2ϩ ions were added in the crystallization solution, it is most likely that the bound Ca 2ϩ ion was copurified with the protein from the expression system and that the trace of Zn 2ϩ ions in the protein solution were nonspecifically bound to the C-terminal hexahistidine tag.
To investigate whether mutations of residues at the metalbinding site would impede Ca 2ϩ binding, the crystal structures of the D1596A, N1602A, and D1596A/N1602A mutants of ssA2 were determined. In all of these mutant structures, the region encompassing residues 1591-1602 still assumed a loop conformation similar to that in the intact ssA2, and there was evident electron density at the metal-binding site corresponding to a bound metal ion. However, because of the loss of ligand(s), the coordination geometries of the metal ion were distorted with a 5-coordination geometry in the D1596A and N1602A mutants and a 4-coordination geometry in the D1596A/N1602A mutant ( Figure 1E-G) . The coordination bond lengths were much longer than those in the ssA2 structure but similar to those in the wtA2 structure ( Figure 1E -G and supplemental Table 1 ). In addition, we collected anomalous dispersion data at the wavelength of 1.77 Å for all of these mutants but no anomalous signal was observed, indicating that the bound ions in the mutants were unlikely to be Ca 2ϩ . These results suggest 
Ca 2؉ binding impedes the unfolding of the A2 domain
To explore the functional role of Ca 2ϩ binding, we conducted simulation studies to examine the effect of Ca 2ϩ binding on the force required for the unfolding of the A2 domain. Based on the ssA2 structure, we constructed a wtA2 model by removing the engineered disulfide bond and then generating a vicinal disulfide bridge between Cys1669 and Cys1670, as observed in the wtA2 structure. The derived wtA2 model was stable in equilibrium MD simulations, the Ca 2ϩ -binding site remained intact, and the ion stayed in place, again indicating that the observed loop conformation of the ␣3-␤4 region and Ca 2ϩ binding were unrelated to the engineered disulfide bond. This model was then subjected to force-probe MD simulations with or without Ca 2ϩ being bound.
The force-probe MD simulation results of the wtA2 model were compared with those of the wtA2 structure. 20 For the initial unfolding of the C-terminal part (␣6, ␤6, and ␣5), the trajectories of the wtA2 model with and without Ca 2ϩ were similar, resembling those of the wtA2 structure. 20 For the unfolding of the central ␤-sheet (strands ␤5 and ␤4), although the force profiles were different for the wtA2 model with a higher force needed to unfold ␤4, in the absence of Ca 2ϩ , the force required for the unfolding of the central ␤-sheet in the simulations of the wtA2 model was almost the same (ϳ1000 pN; Figure 2A left panel) in this study as in the previous report. 20 Intriguingly, when Ca 2ϩ was bound, the force significantly increased to 1250 pN for the unfolding of strand ␤4 (Figure 2A right panel) , indicating that the interplay between Ca 2ϩ and the involved residues at the metal-binding site impedes the unfolding of the A2 domain, in particular the detachment of ␤4 from the remaining protein core. Therefore, binding of Ca 2ϩ renders A2 more resistant against pulling forces such as those present in the shear flow of blood.
When Ca 2ϩ was bound, the trajectories of the unfolding of the ␤4 strand were also different, with the force peak being split into 3 subpeaks representing breakage of interstrand interactions within the central ␤-sheet, the associated movement of the central ␤-sheet, and the stepwise disruption of the Ca 2ϩ -binding site. At the beginning, Asn1602 was pulled away from the Ca 2ϩ -binding site, followed by the movement of ␤4 ( Figure 2B snapshots I and II). After the second subpeak, the Ca 2ϩ ion was only coordinated by Asp1596 and Asp1498 ( Figure 2B snapshot III) . Finally, the 
Ca 2؉ binding protects A2 from cleavage by ADAMTS13
Because unfolding of the A2 domain is essential for the cleavage of VWF by ADAMTS13, we reasoned that the binding of Ca 2ϩ would have an impact on VWF cleavage. This hypothesis was examined using in vitro biochemical assays that included pretreatment of the A2 substrate with urea to facilitate the unfolding process (step I), followed by the proteolysis of A2 by ADAMTS13 (step II) using the wtA2 proteins expressed in HEK293S GNT1 Ϫ cells with glycosylation (see "Discussion") but not the engineered ssA2 proteins as substrates. To investigate the effect of Ca 2ϩ on the unfolding process only, various concentrations of Ca 2ϩ (0mM, 2.5mM, and 5.0mM) were added at step I, whereas the Ca 2ϩ concentration was adjusted to the same (2.5mM which is within the normal range of blood Ca 2ϩ concentration) at step II. As shown in Figure 3A , in the presence of high concentration of urea, the wtA2 protein was cleaved by ADAMTS13; however, supplementation of Ca 2ϩ at the concentration of either 2.5mM or 5.0mM during step I significantly suppressed the process, indicating that Ca 2ϩ binding indeed impedes the unfolding of wtA2 and consequently its cleavage by ADAMTS13 ( Figure 3A) .
Conversely, if Ca 2ϩ exerts a protective function via the Ca 2ϩ -binding site, then the disruption or lack of the Ca 2ϩ -binding site would abolish the protective role of Ca 2ϩ . VWF73 (corresponding to residues Asp1596-Arg1668 of the A2 domain) is the minimal substrate of ADAMTS13 that is presumably unfolded and susceptible to the cleavage by ADAMTS13 without shear stress or chaotropic agents. 22 VWF73 supposedly does not have a Ca 2ϩ -binding site because of the absence of both Asp1498 and a defined structure. Consistently, pretreatment of VWF73 with Ca 2ϩ had no effect on the cleavage of this fragment ( Figure 3B ), indicating the necessity of an intact Ca 2ϩ -binding site for the protection of VWF by Ca 2ϩ from ADAMTS13 cleavage.
The metalloprotease ADAMTS13 requires Zn 2ϩ33 or Ca 2ϩ7,14 for its activity, and it has been reported that the activity of ADAMTS13 is enhanced approximately 160-fold at 5M Ca 2ϩ34 . Therefore, Ca 2ϩ may have 2 opposing effects on VWF cleavage: stabilization of the A2 domain and enhancement of the enzymatic activity of ADAMTS13. Given that the physiologic concentration of Ca 2ϩ remained stable, this combined effect of Ca 2ϩ was examined with the Ca 2ϩ concentration kept unchanged during step I (corresponding to the unfolding process) and step II (corresponding to the proteolytic process). The results shown in Figure 3C show a similar trend as observed in Figure 3A , again demonstrating that the presence of Ca 2ϩ leads to decreased susceptibility of the VWF A2 domain. Considering that the VWF unfolding and ADAMTS13 cleavage occur in the same environment in vivo, the A2 cleavage assay was further modified so that step I and step II were no longer separated, and the A2 unfolding and ADAMTS13 cleavage were carried out under the same conditions ( Figure 3D ). The results were very similar to those presented in Figure 3C , supporting a protective role of Ca 2ϩ in VWF proteolysis.
Mutations at the Ca 2؉ -binding site impair the protective effect of Ca 2؉ on A2 cleavage
To further investigate the functional role of Ca 2ϩ binding in the protection of the A2 domain, the wtA2 mutants D1596A, D1498A, R1597W, and N1602A, which carry point mutations of the key residues at the Ca 2ϩ -binding site, were analyzed with in vitro cleavage assays. At all 3 urea concentrations examined, the cleavage of the D1596A mutant appeared to be independent of the Ca 2ϩ concentration, implying that the side-chain carboxyl is required for exertion of the protective function of Ca 2ϩ binding ( Figure 4A ). This finding agrees with the critical role of Asp1596 shown by the structural investigations on ssA2 and its D1596A mutant.
The rest of the mutants were examined with 2-step ADAMTS13 cleavage assays with a fixed urea concentration (2.56M) in step I. The D1498A mutant showed a dramatically increased susceptibility to ADAMTS13, and the presence of a high Ca 2ϩ concentration had no effect on the protection of the A2 unfolding in step I ( Figure 4B ). In addition to its participation in the formation of the Ca 2ϩ -binding site, the side-chain carboxyl group of Asp1498 forms a salt bridge with the side-chain amino group of Arg1597, which stabilizes the position of Arg1597. Therefore, mutation of Asp1498 to Ala might lead to instability of this region, which probably facilitates the unfolding of the A2 domain, partially explaining the substantially increased susceptibility of this mutant. The type 2A VWD-associated R1597W mutant showed similar levels of susceptibility to ADAMTS13 in the presence and absence of Ca 2ϩ in step I ( Figure 4B ), indicating that Ca 2ϩ protection of A2 cleavage is abolished by the R1597W mutation. Such an effect might have resulted from a change in the configuration of its main-chain carbonyl due to the introduction of a bulky side chain and the loss of the salt-bridging interaction with Asp1498 and the consequent loss or decrease of coordination with Ca 2ϩ . Intriguingly, the N1602A mutation led to resistance of A2 to the digestion by ADAMTS13 ( Figure 4B) .
The mutations D1596A, N1602A, and R1597W were also investigated for the ADAMTS13 minimal substrate VWF73. As expected, mutations D1596A and R1597W exhibited no effect on the susceptibility of VWF73 to ADAMTS13 proteolysis ( Figure 4C ). Mutation N1602A also led to resistance of the VWF73 fragment to the proteolysis (Figure 4C ), although the protective effect of Ca 2ϩ might have been lost due to the disruption of the Ca 2ϩ -binding site by the N1602A mutation. It has been shown that the range of the recognized cleavage site for ADAMTS13 encompasses residues Arg1597-Ile1623. 35 Our results indicate a critical role of Asn1602 for cleavage of VWF by ADAMTS13, probably because of its proximity to the cleavage site of Tyr1605-Met1606. The detailed functional role(s) of Asn1602 needs to be investigated further.
Discussion
Using structural, computational, and biochemical data, we reveal a novel Ca 2ϩ -binding site at the A2 domain of VWF and show that Ca 2ϩ binding at this site protects its unfolding and subsequent proteolysis by ADAMTS13. The VWF A2 domain shares structural similarities with other VWF A domains. 25, 36, 37 Although binding of metal ions has been reported in VWF A domains, 37 this is the first time that a metal-binding site has been observed in the A domains of VWF, which is different from the metal-binding site of other VWF A domains.
Comparison of the equivalent sites in the ssA2 and wtA2 structures showed that one major difference lies in the position and configuration of Asp1596 ( Figure 1C-D) . In the ssA2 structure, Asp1596 is located in the ␣3-␤4 loop and points its side chain inside to coordinate the bound Ca 2ϩ ion, whereas in the wtA2 structure, Asp1596 resides in the 3 10 helix and the side chain point away from the tentative Ca 2ϩ -binding site. 38 Despite these differences, a molecule was also detected at the site in the wtA2 structure equivalent to the Ca 2ϩ -binding site of ssA2, forming 6 coordination bonds with the surrounding residues and water molecules in a geometry similar to that in our ssA2 structure. However, the bond lengths were much longer than those in the ssA2 structure (2.7-3.3 Å vs 2.3-2.4 Å). Intriguingly, in the D1596A mutant of ssA2, with loss of the coordination of Asp1596, the Ca 2ϩ -binding site was partially assembled as in the wtA2 structure, and similarly, a molecule was bound with longer bond lengths (2.5-2.9 Å). Because this molecule is not a Ca 2ϩ ion based on the anomalous dispersion results, by analogy, the molecule bound at the same position of wtA2 was unlikely to be a Ca 2ϩ ion, implying that the partially assembled site is insufficient for Ca 2ϩ binding. Glycosylation of wtA2 occurs at Gln1515 and Gln1574 of the A2 domain of VWF, and mutation of Gln1574, which prevents its glycosylation, leads to increased susceptibility of VWF and VWF A2 to ADAMTS13 proteolysis. 39 Indeed, in the wtA2 structure, N-linked glycans were observed at Gln1515 and Gly1574. The glycosylation sites and the Ca 2ϩ -binding site were located on opposite sides of the A2 domain, and therefore it is unlikely that glycosylation affected the assembly of the Ca 2ϩ -binding site (supplemental Figure 3) . Examination of the effect of the D1596A mutation on Ca 2ϩ protection of A2. In step I, the D1596A mutant A2 was denatured under different urea concentrations and Ca 2ϩ was supplemented as indicated. In step II, the Ca 2ϩ concentration was adjusted to 2.5mM. The cleaved and intact proteins were detected with Western blotting using the specific antibodies. (B) Examination of the effect of the D1498A, R1597W, and N1602A mutations on Ca 2ϩ protection of A2. In step I, 2.56M urea was added. (C) Examination of the effect of the D1498A, R1597W, and N1602A mutations on the proteolysis of GST-VWF73 by ADAMTS13. No urea was added in step I and the Ca 2ϩ concentration was 2.5mM in both steps.
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To investigate whether the differences in the conformation of the ␣3-␤4 region and Ca 2ϩ binding between the wtA2 and ssA2 structures were due to the different crystallization conditions, we explored the possibilities of obtaining a wtA2 structure with an ssA2 structure without a Ca 2ϩ ion being bound. Attempts to grow crystals of wtA2 under the crystallization conditions reported here and crystals of ssA2 under the conditions reported by Zhang et al 21 were unsuccessful. Instead, we obtained crystals of wtA2 from both the cocrystallization and soaking experiments under the same crystallization conditions used by Zhang et al 21 using supplementation of 10mM CaCl 2 and crystals of the ssA2 protein treated with 10mM EDTA under the crystallization conditions reported here. No Ca 2ϩ signal was detected in the anomalous dispersion diffraction data for these crystals (data not shown). In the derived wtA2 structures, the ␣3-␤4 region assumed the same 3 10 -helical conformation with a molecule bound at the metal-binding site in a way similar to that in the wtA2 structure (data not shown), indicating that the ␣-helical conformation of the ␣3-␤4 region and the incapability of binding a Ca 2ϩ are intrinsic properties of the wtA2 structure under the corresponding crystallization conditions. Conversely, in the structure of EDTA-treated ssA2 determined at a 2.0 Å resolution, the Ca 2ϩ -binding site was almost identical to that in the structure of ssA2 in complex with Ca 2ϩ (supplemental Figure 2B ), although no Ca 2ϩ was bound, implicating that the formation of the binding site in ssA2 is not induced by Ca 2ϩ , but rather occurs naturally under the crystallization conditions.
These results indicate that the loop conformation of the ␣3-␤4 region and the capability of binding a Ca 2ϩ are intrinsic properties of the ssA2 structure under the crystallization conditions reported in this study, and that the observed differences between the wtA2 and ssA2 structures might result from the different crystallization conditions. Analysis of the crystal packing of the 2 crystal forms revealed that the ␣3-␤4 region is exposed on the solvent-accessible surface in both structures and is engaged in the interactions with the symmetry-related molecules in the wtA2 (supplemental Figure 4A) but not the ssA2 structure. Moreover, superposition of the ssA2 structure onto the wtA2 structure showed that in the crystal packing of wtA2, the ␣3-␤4 region of the ssA2 would clash with the symmetry-related molecule (supplemental Figure 4B) . Therefore, the crystal packing in the wtA2 structure hinders the ␣3-␤4 region from forming a loop structure and therefore prevents complete assembly of the Ca 2ϩ -binding site. In solution, it is plausible that the ␣3-␤4 region of VWF A2 might have a high flexibility with the 3 10 -helical conformation seen in the wtA2 structure and the loop conformation seen in the ssA2 structure as 2 quasi-stable conformations, which have been independently captured under different crystallization conditions.
It was reported recently that there is an intermediate unfolded state of A2 that shows unfolding of the C-terminal region up to the ␤4 strand. 19 Of the 5 residues involved in the formation of the Ca 2ϩ -binding site identified in this study, 4 (Asp1596, Arg1597, Ala1600, and Asn1602) were located in the C-terminal region of the ␣3-␤4 loop that immediately flanks the ␤4 strand (supplemental Figure 5 ). Based on the crystal structure of the catalytic domain of ADAMTS5, 40 we constructed a model of ADAMTS13 showing that the active site of the enzyme is a narrow and deep groove (unpublished data), suggesting that the ␤4 strand needs to be displaced and inserted into the groove for ADAMTS13 cleavage. The displacement of the ␤4 strand would require a conformational change of the ␣3-␤4 loop and very likely the disruption of the Ca 2ϩ -binding site as well, which implies that Ca 2ϩ exerts its protective role through stabilization of the ␣3-␤4 loop and thus restraint of the ␤4 strand.
PDB accession codes
The structures of ssA2 and its D1596A, N1602A, and D1596A/ N1602A mutants have been deposited with the RCSB PDB under accession codes 3PPV, 3PPW, 3PPX, and 3PPY, respectively.
